These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 24436135

  • 1. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J.
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
    [Abstract] [Full Text] [Related]

  • 2. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
    Modrego PJ, Fayed N, Errea JM, Rios C, Pina MA, Sarasa M.
    Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
    [Abstract] [Full Text] [Related]

  • 3. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
    Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.
    Psychogeriatrics; 2009 Dec; 9(4):196-203. PubMed ID: 20377821
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P, Tsolaki M, Hort J, Hager K, Soininen H, López Pousa S, Li C, Schwam E.
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [Abstract] [Full Text] [Related]

  • 5. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group.
    JAMA; 2004 Jan 21; 291(3):317-24. PubMed ID: 14734594
    [Abstract] [Full Text] [Related]

  • 6. The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients.
    Zhang N, Wei C, Du H, Shi FD, Cheng Y.
    Dement Geriatr Cogn Disord; 2015 Jan 21; 40(1-2):85-93. PubMed ID: 26066622
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 21; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P, Putignano D, Castagna A, Cotroneo AM, De Palo G, Fabbo A, Forgione L, Giacummo A, Lacava R, Marino S, Simone M, Zurlo A, Putignano S.
    J Alzheimers Dis; 2014 Dec 21; 41(2):633-40. PubMed ID: 24643135
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study.
    Matsuzono K, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K.
    J Alzheimers Dis; 2015 Dec 21; 45(3):771-80. PubMed ID: 25624417
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
    Riordan KC, Hoffman Snyder CR, Wellik KE, Caselli RJ, Wingerchuk DM, Demaerschalk BM.
    Neurologist; 2011 Mar 21; 17(2):121-3. PubMed ID: 21364371
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E, Ligori LD.
    J Alzheimers Dis; 2014 Mar 21; 39(3):477-85. PubMed ID: 24164733
    [Abstract] [Full Text] [Related]

  • 15. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M.
    J Alzheimers Dis; 2013 Mar 21; 35(2):349-61. PubMed ID: 23411693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S, Kameda A, Inagaki T, Horiguchi J.
    Psychiatry Clin Neurosci; 2004 Dec 21; 58(6):660-5. PubMed ID: 15601392
    [Abstract] [Full Text] [Related]

  • 18. Effect of donepezil in patients with Alzheimer's disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study.
    Klinger T, Ibach B, Schoenknecht P, Kamleiter M, Silver G, Schroeder J, Mielke R.
    Curr Med Res Opin; 2005 May 21; 21(5):723-32. PubMed ID: 15969871
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M.
    Psychogeriatrics; 2016 Mar 21; 16(2):85-92. PubMed ID: 25918972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.